Fear of cancer recurrence (FCR) is a significant problem for individuals diagnosed with a variety of different cancers. To date, FCR has not been studied in males with breast cancer. The objective of this study was to examine the severity of FCR in males with breast cancer.
Males with breast cancer participated in an anonymous online survey and completed the Fear of Cancer Recurrence Inventory-Short Form scale (FCRI-SF). A frequency analysis was used to determine the percentage of participants that fell above or below the clinical cutoff for significant FCR. Regressions explored associations between FCR, age, cancer stage, time since diagnosis, and self-health rating.
Fifty-nine participants completed the FCRI-SF. The mean age of the sample was 63.5 and 93% reported their race as white. The mean FCR score was 23.9 and 61% reported clinically significant FCR. More than 80% of the sample experienced at least problematic levels of FCR. Increasing age was associated with decreased FCR.
Results of this study suggest that FCR is prevalent in men with breast cancer but larger studies with representative samples should be undertaken to better assess the prevalence of FCR in this population and compare it with other groups of patients. More attention is needed to understand the psychological distress experienced by men diagnosed and treated for breast cancer.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Data will not be deposited in a repository. Interested researchers are encouraged to contact the corresponding author for data sharing requests.
Simard S, Savard J (2009) Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17(3):241–251
Lebel S et al (2016) From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer 24(8):3265–3268
Gucalp A et al (2019) Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat 173(1):37–48
Dalton KL et al (2021) Associated with “survivor identity” in men with breast cancer. Curr Oncol 28:1696–1705
Smith S, Savard J (2015) Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv 9(3):481–491
Smith AB et al (2020) Spotlight on the Fear of Cancer Recurrence Inventory (FCRI). Psychol Res Behav Manag 13:1257–1268
Mutsaers et al (2019) Identifying the key characteristics of clinical fear of cancer recurrence: an international Delphi study. Psychooncology 29(2):430–436
Simard S et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7(3):300–322
Galica J et al (2021) Examining predictors of fear of cancer recurrence using leventhal’s commonsense model: distinct implications for oncology nurses. Cancer Nurs 44(1):3–12
Black EK, White CA (2005) Fear of recurrence, sense of coherence and posttraumatic stress disorder in haematological cancer survivors. Psychooncology 14(6):510–515
Quincey K, Williamson I, Winstanley S (2016) “Marginalised malignancies”: a qualitative synthesis of men’s accounts of living with breast cancer. Soc Sci Med 149:17–25
Nguyen TS et al (2020) Living with male breast cancer: a qualitative study of men’s experiences and care needs. Breast Care (Basel) 15(1):6–12
Tauber NM et al (2019) Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol 37(31):2899–2915
We thank all the men who took our survey and the Male Breast Cancer Coalition and the Breast Cancer Network Australia for help with recruitment. We also thank Drs. Josh Rash and Eric Wibowo for reviewing our survey prior to launch.
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by Memorial University’s Health Research Ethics Board (No: # 2019.249). The authors affirm that all human research participants in this study participants provided informed consent to participate.
Consent for publication
The authors affirm that all human research participants in this study provided informed consent for publication.
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Dalton, K., Waterman, M., Wassersug, R. et al. Fear of cancer recurrence in males diagnosed with breast cancer. Support Care Cancer 29, 6183–6186 (2021). https://doi.org/10.1007/s00520-021-06307-5
- Male breast cancer
- Fear of cancer recurrence
- Male cancers
- Sex/gender differences